✦ LIBER ✦

PND5 Budget Impact Analysis of Fingolimod for the Treatment of Multiple Sclerosis in Colombia

✍ Scribed by D. Rosselli; J.G. Ariza Lozano; T. Acosta; J.D. Rueda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND4 BUDGET IMPACT ANALYSIS OF NATALIZUM

✍ AL Ferreira Da Silva; A Finkelsztejn; R Ribeiro; CA Polanczyk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PND11 Budget Impact Analysis of First-Li

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND30 NATIONAL GUIDELINE FOR MULTIPLE SC

✍ RLP Bueno; MF Pereira 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PND38 Cost Minimization Analysis of Fing

✍ Crespo, C.; Izquierdo, G.; García-Ruiz, A.; Granell, M.; Brosa, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PND23 Economic Evaluation of Natalizumab

✍ S.T. Alexopoulos; B. Deniz; A.R. Walker; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PND30 Cost Analysis of Glatiramer Acetat

✍ Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB